Gautam Mehta - Natl Inst Neurol Disorders & Stroke, NIH

基本信息

Career Trajectory

Bio

Gautam Mehta is a Clinical Scientist at the House Ear Institute. His current research focuses on Neurofibromatosis Type 2, skull-base tumors, acoustic neuromas, and peripheral nerve tumors.

Research Interests

Papers共 126 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Facial Nerve Schwannoma Treatment with Stereotactic Radiosurgery (SRS) Versus Resection Followed by SRS: Outcomes and a Management Protocol

Sam Dayawansa,Chloe Dumot,Georgios Mantziaris,Gautam U. Mehta,Gregory P. Lekovic,Douglas Kondziolka,David Mathieu,Wael A. Reda,Roman Liscak,Lee Cheng-chia,Anthony M. Kaufmann, Gene Barnet,Daniel M. Trifiletti,L. Dade Lunsford,Jason Sheehan

JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE（2024）

Cited0Views0WOSBibtex

Endolymphatic Sac Tumors in von Hippel-Lindau Disease

Laura H. Christopher,Gregory P. Lekovic,Gautam U. Mehta

Von Hippel-Lindau Diseasepp.125-140, (2024)

Cited0Views0Bibtex

FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for Unresectable or Metastatic Non-Small Cell Lung Cancer with Activating HER2 Mutations

Gautam U. Mehta,Paz J. Vellanki, Yi Ren,Anup K. Amatya,Pallavi S. Mishra-Kalyani, Lili Pan,Jeanne F. Zirkelbach,Yuzhuo Pan,Jiang Liu,Stephanie L. Aungst,Claudia P. Miller,Mirat Shah,Nam Atiqur Rahman,Marc Theoret,Paul Kluetz,Richard Pazdur,Julia A. Beaver,Harpreet Singh

The Oncologist (2024)

Cited0Views0WOSBibtex

Project Confirm: Accelerated Drug Approvals for CML-Response

Kendra L Sweet,Jorge E Cortes,Jane F Apperley,Mel Mann,Michael J Mauro,Vivian G Oehler,Cristina Ruiz,Charles A Schiffer,Lori A Ehrlich,Gulsum E Pamuk,Joseph Wynne,Gautam U Mehta,Olanrewaju O Okusanya,R Angelo de Claro,Marc R Theoret,B Douglas Smith,Kelly J Norsworthy

Clinical cancer researchno. 1 (2024): 237-238

Cited0Views0WOSBibtex

FDA Analysis of Immune Checkpoint Inhibitors in Combination with Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors in the Second-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer

Justin Nathaniel Malinou,Gautam Mehta,Paz J. Vellanki,Erin A. Larkins,Paul Gustav Kluetz,Harpreet Singh

Journal of Clinical Oncologyno. 16_suppl (2024): 8595-8595

Cited0Views0Bibtex

Figure S7 from Acetylation within the N- and C-Terminal Domains of Src Regulates Distinct Roles of STAT3-Mediated Tumorigenesis

Chao Huang,Zhe Zhang,Lihan Chen,Hank W. Lee,Marina K. Ayrapetov,Ting C. Zhao,Yimei Hao,Jinsong Gao,Chunzhang Yang,Gautam U. Mehta,Zhengping Zhuang,Xiaoren Zhang,Guohong Hu,Y. Eugene Chin

crossref（2023）

Cited0Views0Bibtex

Use of Single-Arm Trials for US Food and Drug Administration Drug Approval in Oncology, 2002-2021

Sundeep Agrawal,Shaily Arora,Laleh Amiri-Kordestani,R. Angelo de Claro,Lola Fashoyin-Aje,Nicole Gormley,Tamy Kim,Steven Lemery,Gautam U. Mehta,Emma C. Scott,Harpreet Singh,Shenghui Tang,Marc R. Theoret,Richard Pazdur,Paul G. Kluetz,Julia A. Beaver

JAMA Oncology（2023）

Cited10Views0WOSBibtex

Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia

Kendra L. Sweet,Jorge E. Cortes,Jane F. Apperley,Mel Mann,Michael J. Mauro,Vivian G. Oehler,Cristina Ruiz,Charles A. Schiffer,Lori A. Ehrlich,Gulsum E. Pamuk,Joseph Wynne,Gautam U. Mehta,R. Angelo de Claro,Marc R. Theoret,B. Douglas Smith,Kelly J. Norsworthy

CLINICAL CANCER RESEARCH（2023）

Cited0Views0WOSBibtex

FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response

Jaleh Fallah,Chana Weinstock,Gautam U. Mehta,Michael H. Brave,William F. Pierce,Richard Pazdur,Abhilasha Nair,Daniel L. Suzman,Laleh Amiri-Kordestani

Clinical cancer research : an official journal of the American Association for Cancer Research（2023）

Cited5Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn